Avita Medical | 1811094D - Ebit



Avita Medical reported AUD-10272000 in EBIT for its fiscal semester ending in December of 2024.


Ebit Change Date
Adcock Ingram Holdings ZAR 541.46M 52.57M Jun/2023
Celltrion KRW 242.47B 93.05B Jun/2025
Clinuvel Pharmaceuticals AUD 32.21M 14.41M Jun/2024
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Cspc Pharmaceutical CNY 1.51B 748.2M Mar/2025
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Divis Laboratories Ltd 6.17B 2.48B Jun/2025
Kangmei Pharma CNY 16.43M 19.69M Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 27.48M 95.85M Jun/2025
Malin Corporation EUR -2200000 800K Jun/2023
Mayne Pharma AUD -16200000 13.2M Jun/2024
Medical Developments International AUD -12124000 3.97M Jun/2023
Nanosonics AUD 8.7M 2.6M Dec/2024
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organigram Holdings CAD -2105000 9.2M Jun/2025
Pacific Edge NZD -16918000 960K Mar/2024
Paradigm Biopharmaceuticals AUD -19930150 12.02M Jun/2023
Pharma Mar EUR 24.15M 27.24M Jun/2025
Polynovo AUD 840K 147K Jun/2024
PYC Therapeutics AUD -25838000 3M Dec/2024
Qiagen NV USD 134.43M 9.77M Jun/2025
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 456.57M 20.65M Jun/2025
Sartorius EUR 161.8M 1.8M Jun/2025
Sino Biopharmaceutical CNY 3.42B 453.21M Jun/2023
Telix Pharmaceuticals AUD 37.44M 16.38M Dec/2024
Tilray USD -42218000 5.65M Nov/2024
Zz Pientze Pharmaceu 485.72M 705.85M Jun/2025